Attenuated response of myocardial flow reserve to lipid-lowering therapy with atorvastatin in patients with familial hypercholesterolemia.

被引：0
|
作者：
Ishida, Y
Tsushima, M
Fukuchi, K
Miyake, Y
Sagoh, M
Oka, H
机构：
[1] Natl Cardiovasc Ctr, Dept Radiol & Nucl Med, Suita, Osaka 565, Japan
[2] Natl Cardiovasc Ctr, Dept Cardiol, Suita, Osaka 565, Japan
来源：
JOURNAL OF NUCLEAR MEDICINE | 2003年 / 44卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
171
引用
收藏
页码：54P / 54P
页数：1
相关论文
共 50 条
  • [1] Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin
    Guethlin, M
    Kasel, AM
    Coppenrath, K
    Ziegler, S
    Delius, W
    Schwaiger, M
    CIRCULATION, 1999, 99 (04) : 475 - 481
  • [2] Lipid-lowering effect of atorvastatin in homozygous familial hypercholesterolemia patients with portocaval anastomosis
    Gaudet, D
    Couture, P
    Tremblay, G
    Brun, D
    Perron, P
    Bergeron, J
    Gagne, C
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 124 - 124
  • [3] ADHERENCE TO LIPID-LOWERING THERAPY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V.
    Kuznetsova, T.
    ATHEROSCLEROSIS, 2018, 275 : E174 - E175
  • [4] Lipid-lowering with atorvastatin in children and adolescents with familial hypercholesterolemia: Impact on endothelial dysfunction
    McCrindle, BW
    McIntyre, S
    Helden, E
    Conner, WT
    CIRCULATION, 2003, 108 (17) : 610 - 610
  • [5] Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy
    Galema-Boers, Annette M.
    Lenzen, Mattie J.
    Engelkes, Sophie R.
    Sijbrands, Eric J.
    van Lennep, Jeanine E. Roeters
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (02) : 409 - 416
  • [6] ADHERENCE AND EFFICIENCY OF LIPID-LOWERING THERAPY IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN RUSSIA
    Ezhov, M. V.
    Tmoyan, N. A.
    Rozhkova, T. A.
    Duplyakov, D. V.
    Salchenko, V. A.
    Kachkovskii, M. A.
    Shaposhnik, I. I.
    Genkel, V. V.
    Gurevich, V. S.
    Urazgildeeva, S. A.
    Tregubov, A. V.
    Muzalevskaya, M. V.
    Bazhan, S. S.
    Timoshenko, O. V.
    Urvanceva, I. A.
    Kozhokar, K. G.
    Sokolov, A. A.
    Tishko, V. V.
    Boeva, O. I.
    Bolotova, E. V.
    Namitokov, A. M.
    Kushnareva, Y. B.
    Kuznetsova, T. Y.
    Korneva, V. A.
    Bogdanov, D. Y.
    Chichina, E. E.
    Soloviev, V. M.
    Ershova, A. I.
    Meshkov, A. N.
    Makogonenko, V. I.
    Galyavich, A. S.
    Sadykova, D. I.
    Pomogaybo, B. V.
    Barbarash, O. L.
    Kashtalap, V. V.
    Shutemova, E. A.
    Isaeva, I. G.
    Khokhlov, R. A.
    Oleynikov, V. E.
    Avdeeva, I. V.
    Chubykina, U. V.
    Bliznyuk, S. A.
    Alieva, A. S.
    Ovsyannikova, V. V.
    Furmenko, G. I.
    Chernykh, T. M.
    Abashina, O. E.
    Djanibekova, A. R.
    Slastnikova, E. S.
    Galimova, L. F.
    ATHEROSCLEROSIS, 2020, 315 : E43 - E43
  • [7] GENETIC MUTATIONS AND LIPID-LOWERING RESPONSE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Kim, H.
    Lee, S. H.
    ATHEROSCLEROSIS, 2020, 315 : E97 - E98
  • [8] Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia
    Capra, Maria Elena
    Biasucci, Giacomo
    Banderali, Giuseppe
    Vania, Andrea
    Pederiva, Cristina
    CHILDREN-BASEL, 2024, 11 (02):
  • [9] Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia
    Ferrari, Filipe
    Martins, Vitor M.
    Rocha, Viviane Z.
    Santos, Raul D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (04) : 483 - 495
  • [10] EVALUATION OF LIPID-LOWERING THERAPY IN PATIENTS WITH DEFINITE DIAGNOSIS OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN LODZ
    Gorzelak-Pabis, P.
    Pawlos, A.
    Staciwa, Z.
    Krulikowska, A.
    Broncel, M.
    ATHEROSCLEROSIS, 2022, 355 : E225 - E226
12345